SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $684,000 | -85.6% | 23,643 | -84.0% | 0.00% | -86.7% |
| Q1 2022 | $4,766,000 | +985.6% | 147,469 | +698.2% | 0.02% | +275.0% |
| Q2 2020 | $439,000 | +45.8% | 18,475 | +10.5% | 0.00% | 0.0% |
| Q1 2020 | $301,000 | -26.8% | 16,716 | -3.5% | 0.00% | +100.0% |
| Q4 2019 | $411,000 | +70.5% | 17,320 | +330.4% | 0.00% | +100.0% |
| Q2 2018 | $241,000 | -2.4% | 4,024 | -25.5% | 0.00% | 0.0% |
| Q1 2018 | $247,000 | -95.8% | 5,399 | -96.3% | 0.00% | -95.7% |
| Q3 2017 | $5,825,000 | +2727.7% | 145,625 | +2940.8% | 0.02% | +2200.0% |
| Q2 2017 | $206,000 | -92.5% | 4,789 | -95.7% | 0.00% | -93.8% |
| Q3 2016 | $2,741,000 | – | 110,847 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |